484 related articles for article (PubMed ID: 30930410)
1. Role of NLRP3 Inflammasome in Cardiac Inflammation and Remodeling after Myocardial Infarction.
Takahashi M
Biol Pharm Bull; 2019; 42(4):518-523. PubMed ID: 30930410
[TBL] [Abstract][Full Text] [Related]
2. Cell-Specific Roles of NLRP3 Inflammasome in Myocardial Infarction.
Takahashi M
J Cardiovasc Pharmacol; 2019 Sep; 74(3):188-193. PubMed ID: 31356542
[TBL] [Abstract][Full Text] [Related]
3. Activation in M1 but not M2 Macrophages Contributes to Cardiac Remodeling after Myocardial Infarction in Rats: a Critical Role of the Calcium Sensing Receptor/NRLP3 Inflammasome.
Liu W; Zhang X; Zhao M; Zhang X; Chi J; Liu Y; Lin F; Fu Y; Ma D; Yin X
Cell Physiol Biochem; 2015; 35(6):2483-500. PubMed ID: 25967877
[TBL] [Abstract][Full Text] [Related]
4. The NLRP3 inflammasome in acute myocardial infarction.
Toldo S; Abbate A
Nat Rev Cardiol; 2018 Apr; 15(4):203-214. PubMed ID: 29143812
[TBL] [Abstract][Full Text] [Related]
5. Calcium-Sensing Receptor on Neutrophil Promotes Myocardial Apoptosis and Fibrosis After Acute Myocardial Infarction via NLRP3 Inflammasome Activation.
Ren Z; Yang K; Zhao M; Liu W; Zhang X; Chi J; Shi Z; Zhang X; Fu Y; Liu Y; Yin X
Can J Cardiol; 2020 Jun; 36(6):893-905. PubMed ID: 32224080
[TBL] [Abstract][Full Text] [Related]
6. P2X
Yin J; Wang Y; Hu H; Li X; Xue M; Cheng W; Wang Y; Li X; Yang N; Shi Y; Yan S
J Cell Mol Med; 2017 Nov; 21(11):2695-2710. PubMed ID: 28470940
[TBL] [Abstract][Full Text] [Related]
7. The cardiac glycoside ouabain activates NLRP3 inflammasomes and promotes cardiac inflammation and dysfunction.
Kobayashi M; Usui-Kawanishi F; Karasawa T; Kimura H; Watanabe S; Mise N; Kayama F; Kasahara T; Hasebe N; Takahashi M
PLoS One; 2017; 12(5):e0176676. PubMed ID: 28493895
[TBL] [Abstract][Full Text] [Related]
8. Hydrogen-Rich Saline Attenuated Subarachnoid Hemorrhage-Induced Early Brain Injury in Rats by Suppressing Inflammatory Response: Possible Involvement of NF-κB Pathway and NLRP3 Inflammasome.
Shao A; Wu H; Hong Y; Tu S; Sun X; Wu Q; Zhao Q; Zhang J; Sheng J
Mol Neurobiol; 2016 Jul; 53(5):3462-3476. PubMed ID: 26091790
[TBL] [Abstract][Full Text] [Related]
9. NLRP3 Inflammasome in Acute Myocardial Infarction.
Mauro AG; Bonaventura A; Mezzaroma E; Quader M; Toldo S
J Cardiovasc Pharmacol; 2019 Sep; 74(3):175-187. PubMed ID: 31356555
[TBL] [Abstract][Full Text] [Related]
10. NLRP3 Inflammasome as a Common Denominator of Atherosclerosis and Abdominal Aortic Aneurysm.
Takahashi M
Circ J; 2021 Nov; 85(12):2129-2136. PubMed ID: 33883388
[TBL] [Abstract][Full Text] [Related]
11. The selective NLRP3-inflammasome inhibitor MCC950 reduces myocardial fibrosis and improves cardiac remodeling in a mouse model of myocardial infarction.
Gao R; Shi H; Chang S; Gao Y; Li X; Lv C; Yang H; Xiang H; Yang J; Xu L; Tang Y
Int Immunopharmacol; 2019 Sep; 74():105575. PubMed ID: 31299609
[TBL] [Abstract][Full Text] [Related]
12. CLEC5A knockdown protects against cardiac dysfunction after myocardial infarction by suppressing macrophage polarization, NLRP3 inflammasome activation, and pyroptosis.
Wang X; Hu Y; Wang Y; Shen D; Tao G
Biochem Cell Biol; 2021 Oct; 99(5):655-665. PubMed ID: 33939927
[TBL] [Abstract][Full Text] [Related]
13. Role of NLRP3 inflammasome in the pathogenesis of cardiovascular diseases.
Liu D; Zeng X; Li X; Mehta JL; Wang X
Basic Res Cardiol; 2018 Jan; 113(1):5. PubMed ID: 29224086
[TBL] [Abstract][Full Text] [Related]
14. The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury.
Sandanger Ø; Ranheim T; Vinge LE; Bliksøen M; Alfsnes K; Finsen AV; Dahl CP; Askevold ET; Florholmen G; Christensen G; Fitzgerald KA; Lien E; Valen G; Espevik T; Aukrust P; Yndestad A
Cardiovasc Res; 2013 Jul; 99(1):164-74. PubMed ID: 23580606
[TBL] [Abstract][Full Text] [Related]
15. CircHelz activates NLRP3 inflammasome to promote myocardial injury by sponging miR-133a-3p in mouse ischemic heart.
Bian Y; Pang P; Li X; Yu S; Wang X; Liu K; Ju J; Wu H; Gao Y; Liu Q; Jia Y; Qu Z; Bi X; Mei Z; Yin X; Wang N; Du W; Yang B
J Mol Cell Cardiol; 2021 Sep; 158():128-139. PubMed ID: 34043986
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting NLRP3 Inflammasome Activity in Acute Myocardial Infarction: A Review of Pharmacologic Agents and Clinical Outcomes.
Buckley LF; Libby P
J Cardiovasc Pharmacol; 2019 Oct; 74(4):297-305. PubMed ID: 31356538
[TBL] [Abstract][Full Text] [Related]
17. Role of NLRP3 Inflammasome in Myocardial Ischemia-Reperfusion Injury and Ventricular Remodeling.
Shen S; Wang Z; Sun H; Ma L
Med Sci Monit; 2022 Jan; 28():e934255. PubMed ID: 35042840
[TBL] [Abstract][Full Text] [Related]
18. Glycogen synthase kinase-3β inhibition alleviates activation of the NLRP3 inflammasome in myocardial infarction.
Wang S; Su X; Xu L; Chang C; Yao Y; Komal S; Cha X; Zang M; Ouyang X; Zhang L; Han S
J Mol Cell Cardiol; 2020 Dec; 149():82-94. PubMed ID: 32991876
[TBL] [Abstract][Full Text] [Related]
19. The SGK1 inhibitor EMD638683, prevents Angiotensin II-induced cardiac inflammation and fibrosis by blocking NLRP3 inflammasome activation.
Gan W; Ren J; Li T; Lv S; Li C; Liu Z; Yang M
Biochim Biophys Acta Mol Basis Dis; 2018 Jan; 1864(1):1-10. PubMed ID: 28986310
[TBL] [Abstract][Full Text] [Related]
20. Atherothrombosis and the NLRP3 inflammasome - endogenous mechanisms of inhibition.
Satish M; Agrawal DK
Transl Res; 2020 Jan; 215():75-85. PubMed ID: 31469975
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
